Buy Endocet Online USA Just 12.5% of patients with opioid use disorder were treated with buprenorphine or methadone in recent years, according to the new study.(CRAIG F. WALKER/THE BOSTON GLOBE/GETTY IMAGES)
FAR TOO FEW PEOPLE WITH opioid addiction have had access to the most effective treatments in recent years, a new study suggests.
Furthermore Getting people into high-quality, evidence-based addiction treatment is seen as key to curbing the nation’s deadly opioid epidemic. The new study, published Wednesday in JAMA Network Open, indicates that treatment using buprenorphine or methadone – medications that can help people manage opioid withdrawal – is by far the most effective way to prevent overdoses and hospitalizations, but that people were much less likely to have access to these medications than to other treatments. Buy Endocet Online USA
Furthermore the analysis included nearly 41,000 people with opioid use disorder who had commercial.
people died of opioid overdoses. Furthermore The study find that just 12.5% of patients are treat with buprenorphine or methadone, compared with 59.3% who receive outpatient counseling only and 15.8% who go into residential rehabilitation or detox services.
“We’ve known for years that methadone and buprenorphine are the most effective treatments.
So we have for opioid use disorder,” says Dr. Sarah Wakeman, the study’s lead author and medical director of Massachusetts General Hospital‘s substance use disorders initiative.”I think there’s been a real gap between what science has shown us is most effective and then what actually.
happens in real-world clinical practice.”